Axsome Therapeutics (AXSM) EBT Growth (3y) (2018 - 2026)
Axsome Therapeutics (AXSM) EBT Growth (3y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,132.22 Bn | 67,131.94 Bn | - | 9.34% |
| 2 | Nanobiotix | 1,911.83 Bn | 1,911.77 Bn | - | - |
| 3 | Akari Therapeutics | 973.81 Bn | 973.81 Bn | - | - |
| 4 | BeOne Medicines | 471.45 Bn | 466.66 Bn | 1.35 Bn | 40.43% |
| 5 | Vertex Pharmaceuticals | 122.00 Bn | 114.75 Bn | 2.59 Bn | 12.01% |
| 6 | Regeneron Pharmaceuticals | 69.99 Bn | 61.23 Bn | 3.31 Bn | -1.05% |
| 7 | Belite Bio | 62.68 Bn | 62.68 Bn | - | - |
| 8 | Argenx Se | 55.86 Bn | 50.67 Bn | 1.41 Bn | 86.16% |
| 9 | Alnylam Pharmaceuticals | 37.47 Bn | 34.46 Bn | 959.66 Mn | 48.67% |
| 10 | Axsome Therapeutics | 12.25 Bn | 11.94 Bn | 176.48 Mn | -95.50% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -95.50% |
| Dec 31, 2025 | 22.84% |
| Sep 30, 2025 | -1.76% |
| Jun 30, 2025 | -5.70% |
| Mar 31, 2025 | -14.45% |
| Dec 31, 2024 | -28.68% |
| Sep 30, 2024 | 33.48% |
| Jun 30, 2024 | 28.67% |
| Mar 31, 2024 | -31.00% |
| Dec 31, 2023 | -48.64% |
| Sep 30, 2023 | 35.60% |
| Jun 30, 2023 | 37.54% |
| Mar 31, 2023 | 35.94% |
| Dec 31, 2022 | -34.46% |
| Sep 30, 2022 | 7.27% |
| Jun 30, 2022 | 16.09% |
| Mar 31, 2022 | -53.97% |
| Dec 31, 2021 | -80.65% |
| Sep 30, 2021 | -183.40% |
| Jun 30, 2021 | -187.46% |